Published in Pediatr Infect Dis J on October 01, 1996
Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92
The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J (2008) 2.23
The epidemiology of pneumococcal infection in children in the developing world. Philos Trans R Soc Lond B Biol Sci (1999) 2.17
Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. PLoS Med (2011) 1.54
Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis (2010) 1.53
Between-strain competition in acquisition and clearance of pneumococcal carriage--epidemiologic evidence from a longitudinal study of day-care children. Am J Epidemiol (2009) 1.38
The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya. PLoS One (2012) 1.34
Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya. Infect Immun (2004) 1.22
The dynamics of nasopharyngeal streptococcus pneumoniae carriage among rural Gambian mother-infant pairs. BMC Infect Dis (2010) 1.11
Association of secondhand smoke exposure with pediatric invasive bacterial disease and bacterial carriage: a systematic review and meta-analysis. PLoS Med (2010) 1.11
Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country. Vaccine (2012) 1.07
Age-dependent prevalence of nasopharyngeal carriage of streptococcus pneumoniae before conjugate vaccine introduction: a prediction model based on a meta-analysis. PLoS One (2014) 1.05
Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS One (2014) 1.04
Phenotypic and genotypic characterization of Streptococcus pneumoniae strains colonizing children attending day-care centers in Norway. J Clin Microbiol (2008) 1.03
Understanding the pneumococcus: transmission and evolution. Front Cell Infect Microbiol (2013) 0.94
TLR2 signaling decreases transmission of Streptococcus pneumoniae by limiting bacterial shedding in an infant mouse Influenza A co-infection model. PLoS Pathog (2014) 0.92
Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in two Chilean cities. Clin Diagn Lab Immunol (1998) 0.92
Comparison of the prevalence of common bacterial pathogens in the oropharynx and nasopharynx of gambian infants. PLoS One (2013) 0.91
Influence of patient age on Streptococcus pneumoniae serotypes causing invasive disease. Clin Diagn Lab Immunol (2001) 0.90
Pneumococcal carriage in sub-Saharan Africa--a systematic review. PLoS One (2014) 0.85
Non-typeable Streptococcus pneumoniae carriage isolates genetically similar to invasive and carriage isolates expressing capsular type 14 in Brazilian infants. J Infect (2010) 0.85
Bacterial Density, Serotype Distribution and Antibiotic Resistance of Pneumococcal Strains from the Nasopharynx of Peruvian Children Before and After Pneumococcal Conjugate Vaccine 7. Pediatr Infect Dis J (2016) 0.81
Increasing penicillin and trimethoprim-sulfamethoxazole resistance in nasopharyngeal Streptococcus pneumoniae isolates from Guatemalan children, 2001--2006. Int J Infect Dis (2007) 0.80
A Pneumococcal Carriage Study in Danish Pre-school Children before the Introduction of Pneumococcal Conjugate Vaccination. Open Microbiol J (2012) 0.78
Ten-year surveillance of pneumococcal infections in Temuco, Chile: implications for vaccination strategies. Clin Vaccine Immunol (2007) 0.76
Household transmission of Streptococcus pneumoniae, Alberta, Canada. Emerg Infect Dis (1999) 0.75
Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life. Clin Vaccine Immunol (2016) 0.75
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Averting a malaria disaster. Lancet (1999) 9.40
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32
Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. Lancet (1971) 6.05
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet (1997) 4.32
Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature (1992) 3.93
Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64
Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg (1994) 3.58
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40
Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health (1998) 3.38
Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med (1977) 3.27
Autoimmune disease and parasitic infections in Nigerians. Lancet (1968) 3.22
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
Immunosuppression in children with malaria. Lancet (1972) 3.11
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06
High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03
Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia. Bull World Health Organ (1997) 3.00
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83
Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet (1974) 2.83
Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75
The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J (1994) 2.73
Carriage of pneumococci after pneumococcal vaccination. Lancet (1996) 2.69
Placental malaria. I. Pathological classification. Histopathology (1993) 2.62
Allergic complications of meningococcal disease. II. Immunological investigations. Br Med J (1973) 2.61
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg (2001) 2.54
Assessment of clinical criteria for identification of severe acute lower respiratory tract infections in children. Lancet (1989) 2.51
Deaths in infancy and early childhood in a well-vaccinated, rural, West African population. Ann Trop Paediatr (1987) 2.42
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol (1989) 2.41
The limitations of verbal autopsy in a malaria-endemic region. Ann Trop Paediatr (1994) 2.40
Permethrin-treated bed nets (mosquito nets) prevent malaria in Gambian children. Trans R Soc Trop Med Hyg (1988) 2.40
Treponemal infection and the outcome of pregnancy in a rural area of The Gambia, west Africa. J Infect Dis (1992) 2.39
Impairment of the immune response to vaccination after acute malaria. Lancet (1978) 2.39
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect. Ann Rheum Dis (1997) 2.33
Pallor as a clinical sign of severe anaemia in children: an investigation in the Gambia. Bull World Health Organ (1997) 2.28
Complement and meningococcal infection. Br Med J (1976) 2.28
Evidence for a malaria mitogen in human malaria. Nature (1975) 2.25
Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet (2000) 2.24
Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis (1987) 2.23
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Changes in the pattern of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993. Trop Med Int Health (1997) 2.09
Immunosuppression in murine malaria. II. The effect on reticulo-endothelial and germinal centre function. Clin Exp Immunol (1971) 2.08
Malaria susceptibility and CD36 mutation. Nature (2000) 2.07
Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg (1992) 2.06
Polyarthritis in Western Nigeria. I. Rheumatoid arthritis. Ann Rheum Dis (1969) 2.01
Risk factors for mortality from acute lower respiratory tract infections in young Gambian children. Int J Epidemiol (1993) 1.99
Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa. J Infect Dis (1989) 1.98
Cell-mediated immunity during natural measles infection. J Clin Invest (1978) 1.93
The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J Infect Dis (1982) 1.89
HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet (1991) 1.86
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86
Seasonal variation of paediatric diseases in The Gambia, west Africa. Ann Trop Paediatr (1993) 1.85
The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia. Trans R Soc Trop Med Hyg (1996) 1.84
An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa. Soc Sci Med (1999) 1.84
Socio-economic risk factors for malaria in a peri-urban area of The Gambia. Trans R Soc Trop Med Hyg (1995) 1.83
Malaria prevalence is inversely related to vector density in The Gambia, West Africa. Trans R Soc Trop Med Hyg (1995) 1.82
Mortality from pneumococcal meningitis. Lancet (1976) 1.81
Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health (1998) 1.78
A prospective survey of the outcome of pregnancy in a rural area of the Gambia. Bull World Health Organ (1987) 1.75
Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans R Soc Trop Med Hyg (1996) 1.73
Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet (1997) 1.71
Detection of Streptococcus pneumoniae DNA in blood cultures by PCR. J Clin Microbiol (1994) 1.69
T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature (1985) 1.69
Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia. J Pediatr (1999) 1.68
Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch Dis Child (1990) 1.68
Rheumatoid factor in Nigerian sera. Clin Exp Immunol (1971) 1.67
Etiology of acute lower respiratory tract infections in Gambian children: I. Acute lower respiratory tract infections in infants presenting at the hospital. Pediatr Infect Dis J (1991) 1.66
Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology (1997) 1.66
Importance of enteric bacteria as a cause of pneumonia, meningitis and septicemia among children in a rural community in The Gambia, West Africa. Pediatr Infect Dis J (1994) 1.64
Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. Immunology (1993) 1.64
A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis (1995) 1.61
Effects of measles on the immune response of Nigerian children. Arch Dis Child (1973) 1.60
Pneumococcal disease among children in a rural area of west Africa. Pediatr Infect Dis J (1996) 1.58
Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet (1988) 1.58
Parasite virulence and disease patterns in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A (1994) 1.57
Disruption of Plasmodium falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity. Am J Trop Med Hyg (1992) 1.57
Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. Pediatr Infect Dis J (1991) 1.57
Persistent measles infection in malnourished children. Br Med J (1977) 1.57
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 4. Perceptions of the causes of malaria and of its treatment and prevention in the study area. Trans R Soc Trop Med Hyg (1993) 1.56
Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania. Trans R Soc Trop Med Hyg (2000) 1.55
The epidemiology of multiple-clone Plasmodium falciparum infections in Gambian patients. Parasitology (1991) 1.55
Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology (1994) 1.55